Vergara, Allan E.
HRN: 15-47-52 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2025
CIPROFLOXACIN 500MG (TAB)
03/25/2025
03/31/2025
IV
400 Mg
Q12
Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes